Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Dabigatran etexilate: a new oral thrombin inhibitor.

× No keyword cloud information.

77 in total

Review 1. Balancing ischaemia and bleeding risks with novel oral anticoagulants.

Authors: Usman Baber; Ioannis Mastoris; Roxana Mehran
Journal: Nat Rev Cardiol Date: 2014-11-04 Impact factor: 32.419

2. Stroke Genetics Update: 2011.

Authors: John W Cole; James F Meschia
Journal: Curr Cardiovasc Risk Rep Date: 2011-12-01

Review 3. Direct thrombin inhibitors in cardiovascular disease.

Authors: Kyle A Arsenault; Jack Hirsh; Richard P Whitlock; John W Eikelboom
Journal: Nat Rev Cardiol Date: 2012-05-01 Impact factor: 32.419

Review 4. Benefit-risk assessment of dabigatran in the treatment of stroke prevention in non-valvular atrial fibrillation.

Authors: Sascha Meyer Dos Santos; Sebastian Harder
Journal: Drug Saf Date: 2014-05 Impact factor: 5.606

Review 5. [New anticoagulants. Characteristics, monitoring and management of bleeding].

Authors: K Heidinger; B Kemkes-Matthes
Journal: Med Klin Intensivmed Notfmed Date: 2011-10-20 Impact factor: 0.840

Review 6. Novel oral anticoagulants: pharmacology, coagulation measures, and considerations for reversal.

Authors: Larry R Jackson; Richard C Becker
Journal: J Thromb Thrombolysis Date: 2014-04 Impact factor: 2.300

7. Acute agranulocytosis after oral administration of dabigatran: a rare case report and a short review of literature.

Authors: Sergio Fasullo; Stefania Davì; Gioacchino Cosenza; Francesca Di Franco; Nicola La Manna; Alfonso Giubilato; Graziella Vetrano; Giorgio Maringhini
Journal: J Thromb Thrombolysis Date: 2018-05 Impact factor: 2.300

8. Association of Proton Pump Inhibitors With Reduced Risk of Warfarin-Related Serious Upper Gastrointestinal Bleeding.

Authors: Wayne A Ray; Cecilia P Chung; Katherine T Murray; Walter E Smalley; James R Daugherty; William D Dupont; C Michael Stein
Journal: Gastroenterology Date: 2016-09-14 Impact factor: 22.682

Review 9. Anticoagulant therapy with the oral direct factor Xa inhibitors rivaroxaban, apixaban and edoxaban and the thrombin inhibitor dabigatran etexilate in patients with hepatic impairment.

Authors: Jochen Graff; Sebastian Harder
Journal: Clin Pharmacokinet Date: 2013-04 Impact factor: 6.447

Review 10. Newer clinically available antithrombotics and their antidotes.

Authors: Samuel Lévy
Journal: J Interv Card Electrophysiol Date: 2014-06-18 Impact factor: 1.900